Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (181-190 of 325) with videos related to

Pageof 33
Sort By:
European Journal of Pharmacology|June 16, 1982
Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptorsB Chan, P Seeman, A Davis, et al.
Journal of Medicinal Chemistry|June 1, 1989
2-Haloaporphines as potent dopamine agonistsS Ramsby, J L Neumeyer, D Grigoriadis, et al.
European Journal of Pharmacology|November 14, 1995
Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epideprideP Seeman, H C Guan, H H Van Tol
Advances in Biochemical Psychopharmacology|January 1, 1974
The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesiaP Seeman, A Staiman, T Lee, et al.
Nature|September 30, 1993
Dopamine D4 receptors elevated in schizophreniaP Seeman, H C Guan, H H Van Tol
Cardiovascular Research|March 1, 1993
Beta adrenoceptor recovery after heart failure in the dogG Larosa, P W Armstrong, P Seeman, et al.
Progress in Neuro-Psychopharmacology|January 1, 1981
Solubilized dopamine/neuroleptic receptors (D2-type)B K Madras, A Davis, B Chan, et al.
Lancet (London, England)|April 25, 1987
Dopamine receptor asymmetry in schizophreniaG P Reynolds, C Czudek, N Bzowej, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Brain receptors for antipsychotic drugs and dopamine: direct binding assaysP Seeman, M Chau-Wong, J Tedesco, et al.
Neuroreport|June 13, 2002
Dopamine D2 receptors internalize in their low-affinity stateF Ko, P Seeman, W S Sun, et al.
Pageof 33

Showing results (181-190 of 325) with videos related to

Sort By:
Pageof 33
European Journal of Pharmacology|June 16, 1982
Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptorsB Chan, P Seeman, A Davis, et al.
Journal of Medicinal Chemistry|June 1, 1989
2-Haloaporphines as potent dopamine agonistsS Ramsby, J L Neumeyer, D Grigoriadis, et al.
European Journal of Pharmacology|November 14, 1995
Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epideprideP Seeman, H C Guan, H H Van Tol
Advances in Biochemical Psychopharmacology|January 1, 1974
The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesiaP Seeman, A Staiman, T Lee, et al.
Nature|September 30, 1993
Dopamine D4 receptors elevated in schizophreniaP Seeman, H C Guan, H H Van Tol
Cardiovascular Research|March 1, 1993
Beta adrenoceptor recovery after heart failure in the dogG Larosa, P W Armstrong, P Seeman, et al.
Progress in Neuro-Psychopharmacology|January 1, 1981
Solubilized dopamine/neuroleptic receptors (D2-type)B K Madras, A Davis, B Chan, et al.
Lancet (London, England)|April 25, 1987
Dopamine receptor asymmetry in schizophreniaG P Reynolds, C Czudek, N Bzowej, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1975
Brain receptors for antipsychotic drugs and dopamine: direct binding assaysP Seeman, M Chau-Wong, J Tedesco, et al.
Neuroreport|June 13, 2002
Dopamine D2 receptors internalize in their low-affinity stateF Ko, P Seeman, W S Sun, et al.
Pageof 33